Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miso Kim

Showing results (81-90 of 184) with videos related to

Pageof 19
Sort By:
European Radiology|August 9, 2017
Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detectionHyungjin Kim, Kum Ju Chae, Soon Ho Yoon, et al.
Cancer Research and Treatment|October 30, 2025
Clinical Outcomes and Histologic Subtype-Specific Patterns in Oligometastatic Soft Tissue Sarcoma of the Extremities and Trunk Wall: Implications for Curative Local Ablative TherapyEunkyu Yang, Han-Soo Kim, Jay Hoon Park, et al.
Plos One|November 4, 2017
The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitorsHyungjin Kim, Chang Min Park, Bhumsuk Keam, et al.
The Korean Journal of Internal Medicine|June 27, 2017
Clinicopathological characteristics of extremely young Korean multiple myeloma patients: therapeutic implicationsJunghoon Shin, Youngil Koh, Jeonghwan Youk, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 3, 2025
Wireless Acousto-Piezoelectric Conduit with Aligned Nanofibers for Neural RegenerationSera Jeon, Dabin Kim, Min-Young Jo, et al.
ESMO Open|August 11, 2018
Low-dose nivolumab can be effective in non-small cell lung cancer: alternative option for financial toxicityShin Hye Yoo, Bhumsuk Keam, Miso Kim, et al.
Cancer Research and Treatment|January 18, 2019
Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung CancerSu-Jung Kim, Soyeon Kim, Dong-Wan Kim, et al.
International Journal of Molecular Sciences|November 25, 2023
CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK CellsTahereh Mohammadian Gol, Miso Kim, Ralph Sinn, et al.
The Korean Journal of Internal Medicine|June 29, 2018
Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancerChan-Young Ock, Shin-Hye Yoo, Bhumsuk Keam, et al.
Cancer Immunology, Immunotherapy : CII|December 6, 2017
Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibodyKoung Jin Suh, Se Hyun Kim, Yu Jung Kim, et al.
Pageof 19

Showing results (81-90 of 184) with videos related to

Sort By:
Pageof 19
European Radiology|August 9, 2017
Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detectionHyungjin Kim, Kum Ju Chae, Soon Ho Yoon, et al.
Cancer Research and Treatment|October 30, 2025
Clinical Outcomes and Histologic Subtype-Specific Patterns in Oligometastatic Soft Tissue Sarcoma of the Extremities and Trunk Wall: Implications for Curative Local Ablative TherapyEunkyu Yang, Han-Soo Kim, Jay Hoon Park, et al.
Plos One|November 4, 2017
The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitorsHyungjin Kim, Chang Min Park, Bhumsuk Keam, et al.
The Korean Journal of Internal Medicine|June 27, 2017
Clinicopathological characteristics of extremely young Korean multiple myeloma patients: therapeutic implicationsJunghoon Shin, Youngil Koh, Jeonghwan Youk, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 3, 2025
Wireless Acousto-Piezoelectric Conduit with Aligned Nanofibers for Neural RegenerationSera Jeon, Dabin Kim, Min-Young Jo, et al.
ESMO Open|August 11, 2018
Low-dose nivolumab can be effective in non-small cell lung cancer: alternative option for financial toxicityShin Hye Yoo, Bhumsuk Keam, Miso Kim, et al.
Cancer Research and Treatment|January 18, 2019
Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung CancerSu-Jung Kim, Soyeon Kim, Dong-Wan Kim, et al.
International Journal of Molecular Sciences|November 25, 2023
CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK CellsTahereh Mohammadian Gol, Miso Kim, Ralph Sinn, et al.
The Korean Journal of Internal Medicine|June 29, 2018
Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancerChan-Young Ock, Shin-Hye Yoo, Bhumsuk Keam, et al.
Cancer Immunology, Immunotherapy : CII|December 6, 2017
Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibodyKoung Jin Suh, Se Hyun Kim, Yu Jung Kim, et al.
Pageof 19